Albert Einstein College of Medicine, 1966
Bronx Municipal Hospital and Mount Sinai Hospital
Peter Bent Brigham Hospital - Boston
David and Barbara Milliken Professor of Preventive Cardiology
Director, Preventive Cardiology Program
Ongoing Research Support
1 R18 DK67549-01 (I. Ockene) 7/1/04 – 5/31/08
The Lawrence Latino Diabetes Prevention Program
The primary aim of this proposal is to implement and evaluate a group-based diabetes prevention program for low-income, Latino patients at high risk of developing diabetes. Risk for diabetes will be defined by the use of predictive equations developed by Stern and colleagues, and the primary outcome will be a reduction in risk as defined by the same equations.
1 R18 DK065985-01A1 (Rosal) 9/01/04 – 8/31/08
NIH, NIDDK $455,337
Diabetes Management for Low-Income Hispanic Patients
The overall goal of this randomized clinical trial (RCT) is to test the efficacy of an educationally-and culturally-tailored cognitive-behavioral intervention (CBI) designed to enhance adherence to diabetes self-management behaviors and thus improve glycemic control (HbA1c) among low-income Hispanic individuals with type 2 diabetes mellitus (T2DM). The primary outcome to be evaluated at 4- and 12- months following randomization is improvement in metabolic control (HbA1c). Secondary aims include the evaluation of the efficacy of the program on: 1) Adherence to self-management behaviors; 2) Other relevant factors including LDL-cholesterol, blood pressure (BP), body mass index (BMI) and quality of life (QOL).
H01-HL073912 (M. McDermott, I. Ockene) 7/1/05 – 6/30/09
NIH, NHLBI $270,136 (subcontract amount)
Reducing Risk Factors in Peripheral Arterial Disease
In patients with peripheral arterial disease, this randomized, controlled clinical trial will test the ability of a telephone-counseling intervention to reduce low density lipoprotein cholesterol levels as compared to usual care and attention control conditions, respectively.
1 R21 DK074027-01
NIH/NIDDK (E. Dratz, I. Ockene) 12/1/05-6/30/07
Markers for Type 2 Diabetes and Aptamer Array Diagnostics $47,223
The goal of this project is to identify new biomarkers for type 2 diabetes and pre-diabetes and to ultimately measure new markers in a robust and reliable photoaptamer array diagnostic system.